摘要
目的比较三种控制性超促排卵(COH)方案在体外受精胚胎移植(IVFET)/卵胞浆内单精子注射(ICSI)的临床结果,分析人尿绝经期促性腺激素(HMG)和基因重组促性腺激素(rFSH)的应用价值。方法回顾性分析570例接受IVFET/ICSI的不育患者,采用三种COH方案的情况。A组50个周期,应用HMG;B组81个周期,应用rFSH;C组445个周期,rFSH结合HMG促排卵。结果B组用药天数少于A组(P<0.05),用药安瓿数少于A组和C组,有统计学差异(P<0.05);B组获卵数明显多于A组和C组(P<0.01,P<0.05)。结论COH中应用rFSH可以募集较多的卵泡,三种COH方案的胚胎发育情况、临床妊娠率、胚胎移植结局无显著差异。
Objective To compare the clinical outcome of three kinds of controlled ovarian hyper stmulation programe in women umdergoing in-vitro fertilization (IVF-ET) / intracytoplasmic sperm injection (ICSI) . Methods Clinical data of 570 infertile women(576 cycles) after IVF-ET / ICSI were analyzed retrospectively Following down regulation in a long gonadotro- phin-releasing hormone(GnRH) agonist protocal , patients received three different tropichyperovulation programme according ecanomic situation and ovarian response. Group A 50 cycles , only with HMG ; Group B 81 cycles , only with Gonal-F ; Group C 445 cycles , mixed Gonal-F with HMG. Results The duration of Gn treatment was significantly shorter in group B than group A (P〈0. 05) . The numbers of anpoules in groups B was significantly less than group A and group C (P〈0. 05) . And there were significantly more follicles and more oocytes retrieved in group B than in group A and group C (P〈0.01, P〈0. 05). Conclusion Although there were significantly more follicles and more oocytes retrieved in group B. There was no significant difference in the rates of implantation and pregnancy among three groups.
出处
《华中医学杂志》
2005年第6期405-406,416,共3页
Central China Medical Journal